EU Regulators Warn of Counterfeit Copies of Cancer Drug Herceptin
EU regulators have issued a warning that several batches of the cancer medicine Herceptin (trastuzumab) have been “tampered with,” falsified and reintroduced into the supply chain, potentially putting patients at risk.
High-cost cancer medications like Herceptin have become an increasingly tempting target for thieves and counterfeiters in recent years. While they lack the ready market that some drugs like Viagra have, their extraordinary cost means extraordinary paydays. US officials warned of a similar scare in February 2012, when counterfeit copies of Roche’s Avastin (bevacizumab) were found to have infiltrated the US supply chain. Another batch of the counterfeit drug was found in April 2012.
In the wake of those findings, FDA went after more than a dozen physicians, who were blamed for purchasing the Avastin from unauthorized suppliers in the pursuit of higher profit margins.
Related Posts
Over 1 million fake printing supplies seized in UAE raids
HP today announced that its Anti-counterfeit Program in EMEA (Europe,...
Container Full of 63 lakh Foreign Cigarettes Costing Rs 6.5 cr Seized at JNPT
The Special Intelligence and Investigation Branch seized more than 63 lakh...
Illegal tobacco on Merseyside: Buying cheap cigarettes is not a victimless crime
Tobacco smugglers are putting legitimate shops - and their workers - at risk by...
Ohio is third US state to tighten laws on airbag counterfeiting
Ohio has joined Connecticut and New York in passing legislation that makes...